Rafael E. Carazo Salas

Rafael E. Carazo Salas is the Founder/CEO of CellVoyant and a Research Fellow at The Alan Turing Institute. Rafael E. is also a Professor at the University of Bristol in the School of Cellular and Molecular Medicine, as well as a Co-Founder and Consultant at Adrestia Therapeutics. With previous experience as a Group Leader at various institutions such as the University of Cambridge, ETH Zürich, and The Rockefeller University, Rafael has a strong background in biochemistry and genetics. Rafael E. holds a PhD in Physics & Biology from EMBL & Université Paris VII and has a BSc in Physics from Concordia University.